IRIS Accounts Production v25.4.0.155 06632247 Board of Directors 1.4.24 31.3.25 31.3.25 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh066322472024-03-31066322472025-03-31066322472024-04-012025-03-31066322472023-03-31066322472023-04-012024-03-31066322472024-03-3106632247ns15:EnglandWales2024-04-012025-03-3106632247ns14:PoundSterling2024-04-012025-03-3106632247ns10:Director12024-04-012025-03-3106632247ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3106632247ns10:SmallEntities2024-04-012025-03-3106632247ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3106632247ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3106632247ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3106632247ns10:FullAccounts2024-04-012025-03-3106632247ns10:Director22024-04-012025-03-3106632247ns10:Director32024-04-012025-03-3106632247ns10:Director42024-04-012025-03-3106632247ns10:Director52024-04-012025-03-3106632247ns10:Director62024-04-012025-03-3106632247ns10:RegisteredOffice2024-04-012025-03-3106632247ns5:CurrentFinancialInstruments2025-03-3106632247ns5:CurrentFinancialInstruments2024-03-3106632247ns5:Non-currentFinancialInstruments2025-03-3106632247ns5:Non-currentFinancialInstruments2024-03-3106632247ns5:ShareCapital2025-03-3106632247ns5:ShareCapital2024-03-3106632247ns5:CapitalRedemptionReserve2025-03-3106632247ns5:CapitalRedemptionReserve2024-03-3106632247ns5:RetainedEarningsAccumulatedLosses2025-03-3106632247ns5:RetainedEarningsAccumulatedLosses2024-03-3106632247ns5:FurnitureFittings2024-04-012025-03-3106632247ns5:MotorVehicles2024-04-012025-03-3106632247ns5:ComputerEquipment2024-04-012025-03-3106632247ns5:FurnitureFittings2024-03-3106632247ns5:MotorVehicles2024-03-3106632247ns5:ComputerEquipment2024-03-3106632247ns5:FurnitureFittings2025-03-3106632247ns5:MotorVehicles2025-03-3106632247ns5:ComputerEquipment2025-03-3106632247ns5:FurnitureFittings2024-03-3106632247ns5:MotorVehicles2024-03-3106632247ns5:ComputerEquipment2024-03-3106632247ns5:MotorVehiclesns5:LeasedAssetsHeldAsLessee2024-03-3106632247ns5:MotorVehiclesns5:LeasedAssetsHeldAsLessee2024-04-012025-03-3106632247ns5:MotorVehiclesns5:LeasedAssetsHeldAsLessee2025-03-3106632247ns5:MotorVehiclesns5:LeasedAssetsHeldAsLessee2024-03-3106632247ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3106632247ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3106632247ns5:FinanceLeasesns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3106632247ns5:FinanceLeasesns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3106632247ns5:FinanceLeasesns5:BetweenOneFiveYears2025-03-3106632247ns5:FinanceLeasesns5:BetweenOneFiveYears2024-03-3106632247ns5:FinanceLeases2025-03-3106632247ns5:FinanceLeases2024-03-3106632247ns5:WithinOneYear2025-03-3106632247ns5:WithinOneYear2024-03-3106632247ns5:BetweenOneFiveYears2025-03-3106632247ns5:BetweenOneFiveYears2024-03-3106632247ns5:AllPeriods2025-03-3106632247ns5:AllPeriods2024-03-31
REGISTERED NUMBER: 06632247 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

FOR

BRINK MEDICINES LIMITED

BRINK MEDICINES LIMITED (REGISTERED NUMBER: 06632247)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


BRINK MEDICINES LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2025







DIRECTORS: Dr M S Sira
Dr A Culshaw
Dr T M Webster
Mrs J K Sira
Mrs L J Webster
A B Culshaw





REGISTERED OFFICE: 7 North Brink
Wisbech
Cambridgeshire
PE13 1JU





REGISTERED NUMBER: 06632247 (England and Wales)





ACCOUNTANTS: Wheelers
Chartered Accountants & Tax Consultants
27-29 Old Market
Wisbech
Cambridgeshire
PE13 1NE

BRINK MEDICINES LIMITED (REGISTERED NUMBER: 06632247)

BALANCE SHEET
31 MARCH 2025

31.3.25 31.3.24
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 23,008 22,009

CURRENT ASSETS
Stocks 47,592 45,536
Debtors 5 198,457 198,634
Cash at bank and in hand 211,341 223,085
457,390 467,255
CREDITORS
Amounts falling due within one year 6 206,964 278,581
NET CURRENT ASSETS 250,426 188,674
TOTAL ASSETS LESS CURRENT
LIABILITIES

273,434

210,683

CREDITORS
Amounts falling due after more than one
year

7

(12,914

)

(15,164

)

PROVISIONS FOR LIABILITIES (1,500 ) -
NET ASSETS 259,020 195,519

CAPITAL AND RESERVES
Called up share capital 600 600
Capital redemption reserve 40 40
Retained earnings 258,380 194,879
SHAREHOLDERS' FUNDS 259,020 195,519

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

BRINK MEDICINES LIMITED (REGISTERED NUMBER: 06632247)

BALANCE SHEET - continued
31 MARCH 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 11 November 2025 and were signed on its behalf by:





Dr M S Sira - Director


BRINK MEDICINES LIMITED (REGISTERED NUMBER: 06632247)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

1. STATUTORY INFORMATION

Brink Medicines Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The directors believe that the company is well placed to manage its financial risks successfully and have reasonable expectation that it has adequate resources to continue in operational existence for the foreseeable future. Consequently, it continues to adopt the going concern basis of accounting in preparing the annual financial statements.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Fixtures and fittings - 15% on reducing balance
Motor vehicles - 25% on reducing balance
Office equipment - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

BRINK MEDICINES LIMITED (REGISTERED NUMBER: 06632247)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

2. ACCOUNTING POLICIES - continued

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 11 (2024 - 11 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
and Motor Office
fittings vehicles equipment Totals
£    £    £    £   
COST
At 1 April 2024 23,661 23,934 8,638 56,233
Additions - - 6,704 6,704
Disposals - (4,225 ) - (4,225 )
At 31 March 2025 23,661 19,709 15,342 58,712
DEPRECIATION
At 1 April 2024 21,379 5,069 7,776 34,224
Charge for year 342 3,942 951 5,235
Eliminated on disposal - (3,755 ) - (3,755 )
At 31 March 2025 21,721 5,256 8,727 35,704
NET BOOK VALUE
At 31 March 2025 1,940 14,453 6,615 23,008
At 31 March 2024 2,282 18,865 862 22,009

BRINK MEDICINES LIMITED (REGISTERED NUMBER: 06632247)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

4. TANGIBLE FIXED ASSETS - continued

Fixed assets, included in the above, which are held under finance leases are as follows:
Motor
vehicles
£   
COST
At 1 April 2024
and 31 March 2025 19,709
DEPRECIATION
At 1 April 2024 1,314
Charge for year 3,942
At 31 March 2025 5,256
NET BOOK VALUE
At 31 March 2025 14,453
At 31 March 2024 18,395

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Trade debtors 152,649 152,483
Other debtors 45,808 46,151
198,457 198,634

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Finance leases (see note 8) 2,251 2,070
Trade creditors 120,731 177,852
Taxation and social security 38,125 9,875
Other creditors 45,857 88,784
206,964 278,581

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.3.25 31.3.24
£    £   
Finance leases (see note 8) 12,914 15,164

BRINK MEDICINES LIMITED (REGISTERED NUMBER: 06632247)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

8. LEASING AGREEMENTS

Minimum lease payments fall due as follows:

Finance leases
31.3.25 31.3.24
£    £   
Net obligations repayable:
Within one year 2,251 2,070
Between one and five years 12,914 15,164
15,165 17,234

Non-cancellable
operating leases
31.3.25 31.3.24
£    £   
Within one year 6,300 2,062
Between one and five years 6,300 -
12,600 2,062

9. SECURED DEBTS

The following secured debts are included within creditors:

31.3.25 31.3.24
£    £   
Finance leases 15,165 17,234

The obligations under finance lease agreements are secured over the assets to which they relate.